These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 12459592)

  • 41. MHC-coded unique alloantigens and antitumor immunity.
    Martin WJ
    Transplant Proc; 1981 Dec; 13(4):1837-40. PubMed ID: 7036480
    [No Abstract]   [Full Text] [Related]  

  • 42. Nonequivalence of classical MHC class I loci in ability to direct effective antiviral immunity.
    Pavelko KD; Mendez-Fernandez Y; Bell MP; Hansen MJ; Johnson AJ; David CS; Rodriguez M; Pease LR
    PLoS Pathog; 2012 Feb; 8(2):e1002541. PubMed ID: 22383876
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Junctional biases in the naive TCR repertoire control the CTL response to an immunodominant determinant of HSV-1.
    Wallace ME; Bryden M; Cose SC; Coles RM; Schumacher TN; Brooks A; Carbone FR
    Immunity; 2000 May; 12(5):547-56. PubMed ID: 10843387
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mice transgenic for a gene that encodes a soluble, polymorphic class I MHC antigen.
    Hunziker R; Margulies DH
    Biotechnology; 1991; 16():175-85. PubMed ID: 2007189
    [No Abstract]   [Full Text] [Related]  

  • 45. Transplantation effects of a unique major histocompatibility complex class I mutation.
    Hasenkrug KJ; Stimpfling JH; Winn HJ; Nathenson SG
    Transplantation; 1992 Aug; 54(2):368-71. PubMed ID: 1496547
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diversity and polymorphism in the MHC appear to be generated by a copy mechanism.
    Schulze DH; Pease LR; Yokoyama K; Geier SS; Pfaffenbach GM; Geliebter J; Zeff RA; Rosenblatt BP; Nathenson SG
    Transplant Proc; 1983 Dec; 15(4):2009-12. PubMed ID: 6673203
    [No Abstract]   [Full Text] [Related]  

  • 47. Murine antiviral proliferative and cytotoxic T-cell responses: specificities and role of the H-21 region.
    Kreeb G; Zinkernagel RM
    Transplant Proc; 1981 Mar; 13(1 Pt 2):979-81. PubMed ID: 6973868
    [No Abstract]   [Full Text] [Related]  

  • 48. Treatment of malignancy by direct gene transfer of a foreign MHC class I molecule.
    DeBruyne L
    Cancer Immunol Immunother; 1996 Nov; 43(3):180-9. PubMed ID: 9001572
    [No Abstract]   [Full Text] [Related]  

  • 49. Existence of T lymphocytes manifesting self-reactivity indistinguishable from alloreactivity: implications for self-recognition and MHC polymorphism.
    Altman A; Katz DH
    Transplant Proc; 1981 Dec; 13(4):1863-6. PubMed ID: 6977221
    [No Abstract]   [Full Text] [Related]  

  • 50. Adaptive value of polymorphism in intracellular self/not-self discrimination?
    Forsdyke DR
    J Theor Biol; 2001 Jun; 210(4):425-34. PubMed ID: 11403563
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Marijuana and host resistance to herpesvirus infection.
    Cabral GA; Pettit DA; Fischer-Stenger K
    Adv Exp Med Biol; 1993; 335():95-106. PubMed ID: 7694448
    [No Abstract]   [Full Text] [Related]  

  • 52. Diversity in H-2 genes encoding antigen-presenting molecules is generated by interactions between members of the major histocompatibility complex gene family.
    Pease LR
    Transplantation; 1985 Mar; 39(3):227-31. PubMed ID: 3919478
    [No Abstract]   [Full Text] [Related]  

  • 53. Diversity and polymorphism of the H-2 major histocompatibility complex.
    Transplant Proc; 1983 Dec; 15(4):2007-177. PubMed ID: 6673202
    [No Abstract]   [Full Text] [Related]  

  • 54. On the anomalous nature of the major histocompatibility complex in Syrian hamsters, Hm-1.
    Streilein JW; Duncan WR
    Transplant Proc; 1983 Jun; 15(2):1540-5. PubMed ID: 6603691
    [No Abstract]   [Full Text] [Related]  

  • 55. The concept of adaptive differentiation: relevance to MHC polymorphism, self-recognition, and leukemogenesis.
    Katz DH
    Transplant Proc; 1980 Mar; 12(1):12-5. PubMed ID: 7368283
    [No Abstract]   [Full Text] [Related]  

  • 56. Is allograft rejection a clue to the mechanism promoting MHC polymorphism?
    Andersson L; Pääbo S; Rask L
    Immunol Today; 1987; 8(7-8):206-9. PubMed ID: 25290428
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Structural determinants of T-cell receptor bias in immunity.
    Turner SJ; Doherty PC; McCluskey J; Rossjohn J
    Nat Rev Immunol; 2006 Dec; 6(12):883-94. PubMed ID: 17110956
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Defining the balance between optimal immunity and immunopathology in influenza virus infection.
    Nguyen THO; Rowntree LC; Chua BY; Thwaites RS; Kedzierska K
    Nat Rev Immunol; 2024 May; ():. PubMed ID: 38698083
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CD8
    Menon T; Illing PT; Chaurasia P; McQuilten HA; Shepherd C; Rowntree LC; Petersen J; Littler DR; Khuu G; Huang Z; Allen LF; Rockman S; Crowe J; Flanagan KL; Wakim LM; Nguyen THO; Mifsud NA; Rossjohn J; Purcell AW; van de Sandt CE; Kedzierska K
    Nat Commun; 2024 Apr; 15(1):3387. PubMed ID: 38684663
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prior infection with unrelated neurotropic virus exacerbates influenza disease and impairs lung T cell responses.
    Foo IJ; Chua BY; Clemens EB; Chang SY; Jia X; McQuilten HA; Yap AHY; Cabug AF; Ashayeripanah M; McWilliam HEG; Villadangos JA; Evrard M; Mackay LK; Wakim LM; Fazakerley JK; Kedzierska K; Kedzierski L
    Nat Commun; 2024 Mar; 15(1):2619. PubMed ID: 38521764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.